Clinical Trial Update: Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 clinical trial evaluating the combination of atomoxetine and oxybutynin for pharyngeal muscle control in obstructive sleep apnea, which…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Atomoxetine (Atomoxetine)
• oxybutynin (oxybutynin)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: OSA | Phase 1, Phase 2 | Status: COMPLETED